The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
GraphDTA: predicting drug–target binding affinity with graph neural networks
Abstract
Summary: The development of new drugs is costly, time consuming and often accompanied with safety issues. Drug repurposing can avoid the expensive and lengthy process of drug development by finding new uses for already approved drugs. In order to repurpose drugs effectively, it is useful to know which proteins are targeted by which drugs. Computational models that estimate the interaction strength of new drug–target pairs have the potential to expedite drug repurposing. Several models have been proposed for this task. However, these models represent the drugs as strings, which is not a natural way to represent molecules. We propose a new model called GraphDTA that represents drugs as graphs and uses graph neural networks to predict drug–target affinity. We show that graph neural networks not only predict drug–target affinity better than non-deep learning models, but also outperform competing deep learning methods. Our results confirm that deep learning models are appropriate for drug–target binding affinity prediction, and that representing drugs as graphs can lead to further improvements. Availability of implementation: The proposed models are implemented in Python. Related data, pre-trained models and source code are publicly available at https://github.com/thinng/GraphDTA. All scripts and data needed to reproduce the post hoc statistical analysis are available from https://doi.org/10.5281/zenodo.3603523. Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Drug repositioning: identifying and developing new uses for existing drugs
Ashburn, T. T., & Thor, K. B. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1468 · Cited by 3,237
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P., Hirschman, J. E., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,015
Cited by
Artificial intelligence for natural product drug discovery
Mullowney, M. W., Duncan, K. R., Elsayed, S. S., Garg, N., van der Hooft, J. J. J., Martin, N. I., Meijer, D., Terlouw, B. R., Biermann, F., Blin, K., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00774-7 · Cited by 460
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 435
Graph Neural Networks and Their Current Applications in Bioinformatics
Zhang, X.-M., Liang, L., Liu, L., & Tang, M.-J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.690049 · Cited by 397
Interpretable bilinear attention network with domain adaptation improves drug–target prediction
Bai, P., Miljković, F., John, B., & Lu, H. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-022-00605-1 · Cited by 362
Yang, Z., Zhong, W., Zhao, L., & Yu-Chian Chen, C. (2022) · Chemical Science · doi:10.1039/d1sc05180f · Cited by 344
Zhao, Q., Zhao, H., Zheng, K., & Wang, J. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab715 · Cited by 274
Ye, Q., Hsieh, C.-Y., Yang, Z., Kang, Y., Chen, J., Cao, D., He, S., & Hou, T. (2021) · Nature Communications · doi:10.1038/s41467-021-27137-3 · Cited by 261
Multimodal data integration for oncology in the era of deep neural networks: a review
Waqas, A., Tripathi, A., Ramachandran, R. P., Stewart, P. A., & Rasool, G. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1408843 · Cited by 165
Bai, Q., Liu, S., Tian, Y., Xu, T., Banegas‐Luna, A. J., Pérez‐Sánchez, H., Huang, J., Liu, H., & Yao, X. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1581 · Cited by 156
Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00352 · Cited by 132
(2024) · doi:10.1038/s42256-024-00847-1 · Cited by 108
Perceiver CPI: a nested cross-attention network for compound–protein interaction prediction
Nguyen, N.-Q., Jang, G., Kim, H., & Kang, J. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btac731 · Cited by 83
Song, W., Xu, L., Han, C., Tian, Z., & Zou, Q. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae346 · Cited by 47
Breaking the barriers of data scarcity in drug–target affinity prediction
Pei, Q., Wu, L., Zhu, J., Xia, Y., Xie, S., Qin, T., Liu, H., Liu, T.-Y., & Yan, R. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad386 · Cited by 36
Benchmarking compound activity prediction for real-world drug discovery applications
(2024) · doi:10.1038/s42004-024-01204-4 · Cited by 34
Zhang, H., Fan, H., Wang, J., Hou, T., Saravanan, K. M., Xia, W., Kan, H. W., Li, J., Zhang, J. Z. H., Liang, X., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae281 · Cited by 25
Attention-based approach to predict drug–target interactions across seven target superfamilies
Schulman, A., Rousu, J., Aittokallio, T., & Tanoli, Z. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae496 · Cited by 25
From Proteins to Ligands: Decoding Deep Learning Methods for Binding Affinity Prediction
Gorantla, R., Kubincová, A., Weiße, A. Y., & Mey, A. S. J. S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01208 · Cited by 24
A universal framework for accurate and efficient geometric deep learning of molecular systems
Zhang, S., Liu, Y., & Xie, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-46382-8 · Cited by 24
A Folding-Docking-Affinity framework for protein-ligand binding affinity prediction
Wu, M.-H., Xie, Z., & Zhi, D. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01506-1 · Cited by 19
ICAN: Interpretable cross-attention network for identifying drug and target protein interactions
(2022) · doi:10.1371/journal.pone.0276609 · Cited by 19
GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure
Jeong, H., Cho, Y.-R., Gim, J., Cha, S.-K., Kim, M., & Kang, D. R. (2024) · PLOS ONE · doi:10.1371/journal.pone.0291223 · Cited by 14
Zhang, P., Ma, J., & Chen, T. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3576488 · Cited by 13
Koyama, T., Tsumura, H., Okita, R., Yamazaki, K., Hasegawa, A., Imamura, K., Kato, T., Iwata, H., Kojima, R., Inoue, H., et al. (2026) · Journal of Cheminformatics · doi:10.1186/s13321-026-01155-z · Cited by 9
Zhang, Z., He, X., Long, D., Luo, G., & Chen, S. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae240 · Cited by 8
Nguyen, N.-Q., & Kang, J. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00773 · Cited by 7
Guo, B., Zheng, H., Jiang, H., Li, X., Guan, N., Zuo, Y., Zhang, Y., Yang, H., & Wang, X. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac628 · Cited by 7
DrugForm-DTA: Towards real-world drug-target binding affinity model
Khokhlov, I., Tashchilova, A., Bugaev-Makarovskiy, N., Glushkova, O., Yudin, V., Keskinov, A., Yudin, S., Svetlichnyy, D., & Skvortsova, V. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.09.023 · Cited by 7
BioStructNet: Structure-Based Network with Transfer Learning for Predicting Biocatalyst Functions
Wang, X., Zhou, J., Mueller, J., Quinn, D., Carvalho, A., Moody, T. S., & Huang, M. (2025) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c01391 · Cited by 7
Quantifying the Hardness of Bioactivity Prediction Tasks for Transfer Learning
Fooladi, H., Hirte, S., & Kirchmair, J. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00160 · Cited by 6
Deep learning-based classification model for GPR151 activator activity prediction
Xu, H., Zhang, B., & Liu, Q. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05369-y · Cited by 4
All That Glitters Is Not Gold: Importance of Rigorous Evaluation of Proteochemometric Models
Avdiunina, P., Jamal, S., Gusev, F., & Isayev, O. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00395 · Cited by 4
Utilizing Data Imbalance to Enhance Compound–Protein Interaction Prediction Models
(2025) · doi:10.1002/aisy.202400985 · Cited by 3
Zhang, S., Xie, L., Tiourine, D., & Xie, L. (2026) · Journal of Cheminformatics · doi:10.1186/s13321-026-01227-0 · Cited by 2
Zhang, Y., Ishitani, R., Takemoto, M., & Tomita, A. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01844-0 · Cited by 1
Dai, Y., Tan, X., Wang, H., Ma, G., Xiong, Y., & Qiu, X. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109163
Huang, Q., Wu, Y., Wang, L., Lin, J., Li, Y., Zeng, M., & Li, M. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00799
Metadata
- Authors
- Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-24
- Volume
- 37
- Issue
- 8
- Pages
- 1140-1147
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W3096561213
- Cited by
- 1,220
- References
- 35
- FWCI
- 39.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.